Hematological Malignancies: Molecular Mechanisms and Therapy
Open Access
- 9 March 2025
- journal article
- editorial
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (6) , 2438
Abstract
Hematological malignancies comprise a wide range of relatively rare cancers with a diverse spectrum of biological and clinical presentationsKeywords
This publication has 11 references indexed in Scilit:
- Role of Novel Quantitative Imaging Techniques in Hematological MalignanciesPET Clinics, 2024
- Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genesGenome Medicine, 2024
- Advances in next-generation sequencing and emerging technologies for hematologic malignanciesHaematologica, 2023
- Liquid biopsy in hematological malignancies: current and future applicationsFrontiers in Oncology, 2023
- Long-term outcomes following CAR T cell therapy: what we know so farNature Reviews Clinical Oncology, 2023
- Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and OutcomesTransplantation and Cellular Therapy, 2022
- Single-cell technologies and analyses in hematopoiesis and hematological malignanciesExperimental Hematology, 2021
- Cancer Statistics, 2021CA: A Cancer Journal for Clinicians, 2021
- Spatially resolved transcriptomics adds a new dimension to genomicsNature Methods, 2021
- T cell-engaging therapies — BiTEs and beyondNature Reviews Clinical Oncology, 2020